Bank of America Corporation »

Mersana Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $376k 162k 2.32
2023-09-30 $149k 117k 1.27
2023-06-30 $992k 302k 3.29
2023-03-31 $4.2M 1.0M 4.11
2022-12-31 $4.5M 761k 5.86
2022-06-30 $262k 57k 4.61
2021-12-31 $266k 43k 6.22
2021-06-30 $750k 55k 13.58
2021-03-31 $541k 33k 16.19
2020-12-31 $10M 377k 26.61
2020-09-30 $11M 598k 18.62
2020-06-30 $10M 446k 23.39
2020-03-31 $1.8M 302k 5.83
2019-12-31 $227k 40k 5.74
2019-09-30 $67k 41k 1.64
2019-03-31 $185k 35k 5.32
2018-12-31 $129k 32k 4.05
2018-06-30 $34k 1.9k 17.63
2018-03-31 $74k 4.5k 16.33
2017-12-31 $153k 9.1k 16.79
2017-09-30 $89k 5.2k 16.88